This international registry study demonstrates that patients with cirrhosis are at increased risk of death from COVID-19. Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease.
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study
Journal of Hepatology | Geplaatst op 06.10.2020 12:56